GLP-1 Problems
GLP-1 is powerful. But it needs the right support.
0%
discontinue
GLP-1 therapy
within 12 months
1
0%
regained weight
after stopping
GLP-1 therapy
2
0%
of GLP-1 users
commonly report
GI side-effects
3
$0
annual GLP-1 cost
per patient,
on average
4
References
1
2
3
4
D2Type's GLP-1 Support
Lifestyle first. Medication when appropriate.
We make GLP-1 more effective by building the habits and clinical support around it.
Behavioral readiness check
Before starting GLP-1s, we assess routines, barriers, and support so patients begin set up for success from day one.
Side-effect support
During therapy, we provide practical coaching to manage GI symptoms and keep patients on track every step.
Clinician-ready summaries
We provide clean, decision-ready snapshots summarizing lifestyle adherence and progress so clinicians can adjust follow-ups efficiently with real data.
Transition support
After GLP-1 therapy, we support patients in maintaining progress with a step-down plan to maintain progress when medication changes or stops.
D2Type's GLP-1 Benefits
Proven behavior-change programs that deliver results
D2Type’s platform is validated to help people not just lose weight, but also maintain it. That’s the key to better outcomes and lower long-term costs.
1.4%
Average reduction in HbA1c, sustained over time
10%
Average reduction in BMI , with long-term habit change
80%
Retention rate, 12- months after GLP-1 discontinuation
How D2Type Helps
Smarter GLP-1 stewardship with built-in lifestyle support
Optimize patient selection
Ensure the right patients start at the right time, with readiness and support clearly assessed.
Improve long-term adherence
Improve adherence and reduce avoidable treatment drop-off with proactive support, structured check-ins, and side-effect guidance.
Support lasting outcomes
Deliver durable health outcomes beyond active medication with structured transition planning and ongoing lifestyle reinforcement.
Enable cost efficiency
Protect budgets through smarter utilization and oversight, backed by monitoring, reporting, and clinical guardrails.
Let’s add a little more activity this week.
Great to see your blood glucose drop this week!
D2Type FAQ
Frequently asked questions
from patients
What are GLP-1s?
GLP-1 receptor agonists (often called GLP-1s) are medications that help lower blood sugar in people with type 2 diabetes. Many also support weight loss and are used to treat obesity.
Are there different GLP-1s?
Yes.
There are multiple GLP-1 receptor agonists (often called GLP-1s). They’re mainly prescribed to manage type 2 diabetes and, in some cases, to support weight loss. Different options vary by dose, how they’re taken, how often they’re used, and what they’re officially indicated for. Well-known examples include Wegovy®, Saxenda®, Ozempic®, and Mounjaro®.
How do GLP-1s help with weight loss?
These medications can support weight loss through several mechanisms. They reduce appetite and hunger signals, which often leads to eating less. They also slow stomach emptying, helping you feel full for longer after meals. Many people report less “food noise,” meaning fewer persistent or intrusive thoughts about food that can drive impulsive eating. GLP-1s can also improve how the body responds to insulin and regulates blood sugar, which may further support weight reduction.
Do I need to change what I eat while taking a GLP-1?
Yes.
What you eat still matters while taking a GLP-1. Because these medications often reduce appetite, you may be eating less overall, which makes food quality more important. Aim for an evidence-based, nutrient-dense approach, prioritizing whole foods that deliver protein, fiber, and key vitamins and minerals so every bite counts. That’s why D2Type’s care teams and our AI-powered in-app nutrition tools are designed to support the specific needs of members using GLP-1s.
Do I need to eat protein while I take a GLP-1?
Eating a balanced diet that includes enough protein is always important, and it becomes even more important when you’re taking a GLP-1. Because GLP-1s can lead to rapid weight loss, some of the weight lost may come from lean muscle, not just fat. Research suggests muscle loss can make up a meaningful share of early weight loss (often cited around 25%–39% in the first few months). Losing muscle can slow metabolism and make it harder to maintain results long term, so getting sufficient protein can help protect lean muscle while you’re on therapy.
Should I exercise while I take a GLP-1?
Exercise can help protect muscle while you’re on a GLP-1, especially strength or resistance training, which is one of the best ways to reduce lean muscle loss during weight loss. You don’t need a gym membership or expensive equipment: bodyweight moves and everyday activities (like stairs, squats, or short strength circuits at home) can be enough to get started. In some programs, D2Type offers access to Physical Activity Specialists who can build a personalized plan to help members exercise safely throughout GLP-1 treatment.
What happens when you stop taking GLP-1s?
When you stop taking a GLP-1, the medication’s effects, like reduced hunger and slower digestion—fade, so it’s common for appetite to increase again. For many people, that can lead to weight regain, but it isn’t inevitable.
​
Members who receive support during GLP-1 therapy and after discontinuation are often able to maintain their progress. In a recent analysis, we found that one year after stopping a GLP-1, members largely maintained their weight loss, with an average weight change of just 0.8%.
How does D2Type support members who take GLP-1s?
D2Type supports members through every stage of their GLP-1 journey, with personalized care before starting, during treatment, and after stopping. Members in D2Type’s GLP-1 companion program get access to a health coach, a cardiometabolic specialist, a physical activity specialist, and AI-supported nutrition guidance, designed to drive behaviour change and build the foundation for long-term weight maintenance.